GliaPharm

Geneva, Switzerland

GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.

Sep 2024

Grant

Top Investors

Alzheimer's Drug Discovery FoundationMassChallengeFONGIT Innovation FundGliaven

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are GliaPharm's investors?

GliaPharm's investors include Alzheimer's Drug Discovery Foundation, MassChallenge, FONGIT Innovation Fund, Gliaven.

Where is GliaPharm headquartered?

GliaPharm is headquartered in Geneva, Switzerland.

What does GliaPharm do?

GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.

What stage is GliaPharm at?

GliaPharm is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 17, 2024.

MLA

"GliaPharm — Funding & Investors." VCBacked, September 17, 2024, https://www.vcbacked.co/company/gliapharm. Accessed July 1, 2026.

APA

VCBacked. (2024). GliaPharm — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/gliapharm

Wikipedia (cite web)

{{cite web |title=GliaPharm — Funding & Investors |url=https://www.vcbacked.co/company/gliapharm |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 17, 2024.